Viewing Study NCT04746950


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-04 @ 3:50 AM
Study NCT ID: NCT04746950
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-08
First Post: 2020-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ALICIA (Acalabrutinib in CLL Therapy)
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic lymphocytic leukemia View